Patient’s reported worries | Total | ART eligibility status | Gender | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Eligible | Not eligible | p-value | Males | Females | p-value | |||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |||
Total | 421 | 217 | 204 | 150 | 271 | |||||||
Any worry | 277 | (66) | 141 | (65) | 136 | (67) | 0.715 | 95 | (63) | 182 | (67) | 0.428 |
HIV serostatus disclosure | 69 | (16) | 38 | (18) | 31 | (15) | 0.521 | 23 | (15) | 46 | (17) | 0.663 |
Food and nutrition | 50 | (12) | 25 | (12) | 25 | (12) | 0.816 | 14 | (9) | 36 | (13) | 0.230 |
Use of other medications | 33 | (8) | 20 | (9) | 13 | (6) | 0.278 | 14 | (9) | 19 | (7) | 0.396 |
ART adherence | 28 | (7) | 14 | (6) | 14 | (7) | 0.886 | 8 | (5) | 20 | (7) | 0.420 |
Condom use | 27 | (6) | 13 | (6) | 14 | (7) | 0.715 | 11 | (7) | 16 | (6) | 0.566 |
ARV side effects | 23 | (5) | 15 | (7) | 8 | (4) | 0.177 | 4 | (3) | 19 | (7) | 0.600 |
Will ARVs make me better? | 20 | (5) | 13 | (6) | 7 | (3) | 0.217 | 6 | (4) | 14 | (5) | 0.590 |
Treatment supporter | 13 | (3) | 4 | (2) | 9 | (4) | 0.128 | 5 | (3) | 8 | (3) | 0.829 |
Contraception /child bearing | 14 | (3) | 6 | (3) | 8 | (4) | 0.508 | 3 | (2) | 11 | (4) | 0.259 |
Will ARVS make me worse? | 13 | (3) | 5 | (2) | 8 | (4) | 0.338 | 4 | (3) | 9 | (3) | 0.710 |
Residence outside study area | 12 | (3) | 4 | (2) | 8 | (4) | 0.200 | 1 | (1) | 11 | (4) | 0.063* |
Alcohol use | 11 | (3) | 4 | (2) | 7 | (3) | 0.307 | 7 | (5) | 4 | (1) | 0.049 |
Why not start ART immediately | 11 | (3) | 4 | (2) | 7 | (3) | 0.307 | 4 | (3) | 7 | (3) | 0.959 |
Employment/work issues | 6 | (1) | 4 | (2) | 2 | (1) | 0.455 | 4 | (3) | 2 | (1) | 0.110 |
Spouse’s HIV serostatus | 5 | (1) | 3 | (1) | 2 | (1) | 0.990* | 2 | (1) | 3 | (1) | 0.990 * |
Pill burden | 3 | (1) | 3 | (1) | 0 | (0) | 0.249* | 1 | (1) | 2 | (1) | 0.990* |
HIV-related stigma | 3 | (1) | 2 | (1) | 1 | (0) | 0.599 | 0 | 3 | (1) | 0.196 | |
Cigarette smoking | 1 | (0) | 0 | (0) | 1 | (0) | 0.485* | 1 | (1) | 0 | 0.356 * | |
Others | 50 | (12) | 23 | (11) | 27 | (13) | 0.403 | 15 | (10) | 35 | (13) | 0.376 |